Association of age and performance status with adverse events in older adults with diffuse large B-cell lymphoma receiving frontline R-CHOP therapy: Alliance 151930, a secondary analysis of the phase III trial CALGB 50303 is a research paper published in Journal of Geriatric Oncology (2025). On theSindex it has a DataRank of 0.181. It has been cited 2 times, with 2 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.165
From this paper's citation signal
Citation Network Contribution
0.0161
From 1 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 2 citers.
National Institutes of Health
Grant: UG1 CA189823
National Institutes of Health
Grant: UG1 CA232760
National Institutes of Health
Grant: A151930
Alliance for Clinical Trials in Oncology Foundation
National Cancer Institute
Fields of Study
MeSH Terms
Keywords